RAW Nutrition Joins Forces with The Quality Group in Category-Defining Co-Ownership and Partnership
1.4.2025 15:00:00 CEST | Business Wire | Press Release
RAW Nutrition, the fast growing sport nutrition brand that combines unmatched quality with cutting-edge formulation, today announced its partnership with The Quality Group, the European leader in performance nutrition known for its state-of-the-art product development and uncompromising quality standards. RAW Nutrition, which was recognized in 2024 as the fastest-growing consumer packaged goods company by Inc. 5000, built its reputation by delivering high-performance nutrition trusted by athletes at the highest level, and this strategic partnership allows the company to take that commitment to growth and innovation to the next level.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401643282/en/
RAW Nutrition Joins Forces with The Quality Group in Category-Defining Co-Ownership and Partnership
This alliance combines two like-minded companies that emphasize a shared priority of delivering the highest standards in quality and innovation in the nutrition sector. The Quality Group, with its two leading brands, ESN and More Nutrition, brings in its proven expertise in cutting-edge production and quality, supporting RAW Nutrition in sustainably scaling its brand.
Both companies share a strong focus on community and athletes. As part of this shared commitment, Chris Bumstead – Co-Owner of RAW Nutrition, six-time Mr. Olympia, and one of the most recognized names in the fitness world – will be working closely with The Quality Group to share his expertise in developing high-quality products that athletes and everyday consumers can benefit from. Chris’ second brand, BUM Energy – a dynamic energy drink label – will also become part of The Quality Group’s partnership portfolio.
“After many discussions with several global performance nutrition companies, we decided to enter a partnership with The Quality Group given that they understand all the opportunities and challenges that we’re about to face, and have navigated through them extremely successfully,” said Dom Iacovone, RAW Nutrition Co-Founder and CEO. “Going through our process, it was very important to me to find a strategic partner versus one that would just give us the most money. We have big goals at RAW Nutrition to build this brand as big as it can be and cooperating with The Quality Group is the first step to helping us navigate that.”
RAW Nutrition & The Quality Group: A New Chapter
Effective immediately, RAW Nutrition’s CEO and Co-Founder, Dom Iacovone, and co-owner Chris Bumstead will both become co-owners of The Quality Group.
In the coming months, RAW Nutrition will focus on growing their product offering and presence in the US market, reaching current and new consumers in new ways.
"Both RAW Nutrition and The Quality Group are rooted in strong communities,” said Heikki Takala, CEO of The Quality Group. “Just as RAW Nutrition engages and fuels athletes in the US, The Quality Group’s brands ESN and More Nutrition engage and enable a loyal, performance-driven customer base in Europe. This strategic partnership enables us to elevate our commitment to our communities, and we are excited to get to join forces with Dom and Chris Bumstead, who are successful entrepreneurs. Chris is a true global icon in our industry, and we believe this is great news for our community.”
RAW Nutrition and The Quality Group will remain independent partners as they seek to build long-term value for their consumers. Lazard acted as financial advisor and Fredrikson & Byron P.A. acted as legal advisor to RAW Nutrition.
What is RAW Nutrition
RAW Nutrition combines unmatched quality with cutting-edge formulation to provide athletes with the best fuel for peak performance, recovery, and overall well-being.
Product Snapshot:
- CBUM Itholate Protein (MSRP $54.99): Formulated by Chris Bumstead himself, this 25g pure whey isolate blend is engineered for lean muscle growth and rapid recovery.
- Creatine Monohydrate (MSRP $12.99): Spikes strength, generates muscular power, and improves muscle fullness.
- Essential Pre-Workout(MSRP $26.99): A powerhouse formula designed for all lifters from beginner to advanced, packing 4g L-Citrulline for serious pumps and 3.2g Beta Alanine to delay fatigue.
- RAW Grass Fed Whey Protein(MSRP: $49.49): Pure, grass-fed whey protein isolate, this high-quality, fast-digestive 25g protein powder supports muscle growth and recovery.
- Ready to Drink Protein Shake(MSRP $4.25): Raw Nutrition’s top-selling protein in a ready-to-drink format. 30g micro-filtered, grass-fed protein isolate, no fillers, no dyes—just pure fuel on the go.
To shop RAW Nutrition’s products or to learn more, visit getrawnutrition.com, or follow them on Instagram, LinkedIn, TikTok or YouTube.
About RAW Nutrition
RAW Nutrition is led by Dr. Domenic Iacovone, six-time Classic Physique Mr. Olympia Champion Chris Bumstead, and renowned bodybuilding coach Matt Jansen.Since its inception in 2019, RAW Nutrition has been recognized as the #1 fastest-growing sports nutrition company by Inc. 5000 and was named Brand of the Year by GNC and Vitamin Shoppe. All RAW Nutrition products are made with premium, clean ingredients, free from unnecessary fillers and additives. RAW Nutrition proudly carries the Informed-Sport certification, a mark of excellence that guarantees its products are rigorously tested for prohibited substances.
About The Quality Group
The Quality Group is the leading sports nutrition, supplements and health food company based in Germany. The company operates a unique digital direct-to-consumer & social commerce business model with its own production, logistics and technology. The two brands "ESN" and "More Nutrition" are strongly rooted in their respective communities and offer better-for-you and performance nutrition to help their customers to live a better life and achieve their personal goals. The Quality Group is headquartered in Elmshorn and employs more than 1.200 people. In 2023, the company generated revenues of more than EUR 680 million. The Quality Group is owned by its founders, an experienced management team and CVC Capital Partners, one of the leading Private Equity companies globally.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401643282/en/
Contacts
Press Contact
Taylor Georgeson
Jack Taylor PR
raw@jacktaylorpr.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom